4.7 Article

Association Between Postoperative Troponin Levels and 30-Day Mortality Among Patients Undergoing Noncardiac Surgery

期刊

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
卷 307, 期 21, 页码 2295-2304

出版社

AMER MEDICAL ASSOC
DOI: 10.1001/jama.2012.5502

关键词

-

资金

  1. Roche Diagnostics Global Office
  2. Public Policy Research Fund
  3. Research Grant Council
  4. Hong Kong SAR
  5. Australian College of Anesthesiologists
  6. New Zealand College of Anesthesiologists
  7. Instituto de Salud Carlos III
  8. Fundacio La Marato de TV3
  9. Canadian Institutes of Health Research
  10. Pfizer Canada
  11. Spanish Health Ministry
  12. Manitoba Medical Services Foundation
  13. Manitoba Health Research Council
  14. Univerity of Manitoba Department of Surgery
  15. Health Sciences Research Foundation
  16. Abbott
  17. AstraZeneca
  18. National Health and Medical Research Council (Australia)
  19. Christian Medical College, Ludhiana
  20. McMaster University
  21. National Institute for Health Research (UK)
  22. Circassia Holdings plc
  23. LiDCo Ltd
  24. Covidien Inc
  25. Pulsion Medical Systems, Edwards Lifesciences
  26. Sanofi
  27. GlaxoSmithKline
  28. Roche
  29. Beckman
  30. Smith Nephew
  31. DePuy
  32. American Heart Association
  33. Heart and Stroke Foundation of Ontario
  34. Academic Health Science Centres
  35. Population Health Research Institute
  36. Clarity Research Group
  37. Department of Surgery
  38. Surgical Associates Research Grant
  39. Hamilton Health Science New Investigator Fund Grant
  40. Hamilton Health Sciences Grant
  41. Ontario Ministry of Resource and Innovation
  42. Stryker Canada
  43. McMaster University, Department of Anesthesiology
  44. Saint Joseph's Healthcare-Department of Medicine
  45. Father Sean O'Sullivan Research Centre
  46. McMaster University-Department of Medicine
  47. Hamilton Health Sciences Summer Studentships
  48. McMaster University-Department of Clinical Epidemiology and Biostatistics
  49. McMaster University-Division of Cardiology
  50. Canadian Network Centre for Trials

向作者/读者索取更多资源

Context Of the 200 million adults worldwide who undergo noncardiac surgery each year, more than 1 million will die within 30 days. Objective To determine the relationship between the peak fourth-generation troponin T (TnT) measurement in the first 3 days after noncardiac surgery and 30-day mortality. Design, Setting, and Participants A prospective, international cohort study that enrolled patients from August 6, 2007, to January 11, 2011. Eligible patients were aged 45 years and older and required at least an overnight hospital admission after having noncardiac surgery. Main Outcome Measures Patients' TnT levels were measured 6 to 12 hours after surgery and on days 1, 2, and 3 after surgery. We undertook Cox regression analysis in which the dependent variable was mortality until 30 days after surgery, and the independent variables included 24 preoperative variables. We repeated this analysis, adding the peak TnT measurement during the first 3 postoperative days as an independent variable and used a minimum P value approach to determine if there were TnT thresholds that independently altered patients' risk of death. Results A total of 15 133 patients were included in this study. The 30-day mortality rate was 1.9% (95% CI, 1.7%-2.1%). Multivariable analysis demonstrated that peak TnT values of at least 0.02 ng/mL, occurring in 11.6% of patients, were associated with higher 30-day mortality compared with the reference group (peak TnT <= 0.01 ng/mL): peak TnT of 0.02 ng/mL (adjusted hazard ratio [aHR], 2.41; 95% CI, 1.33-3.77); 0.03 to 0.29 ng/mL (aHR, 5.00; 95% CI, 3.72-6.76); and 0.30 ng/mL or greater (aHR, 10.48; 95% CI, 6.25-16.62). Patients with a peak TnT value of 0.01 ng/mL or less, 0.02, 0.03-0.29, and 0.30 or greater had 30-day mortality rates of 1.0%, 4.0%, 9.3%, and 16.9%, respectively. Peak TnT measurement added incremental prognostic value to discriminate those likely to die within 30 days for the model with peak TnT measurement vs without (C index=0.85 vs 0.81; difference, 0.4; 95% CI, 0.2-0.5; P<.001 for difference between C index values). The net reclassification improvement with TnT was 25.0% (P<.001). Conclusion Among patients undergoing noncardiac surgery, the peak postoperative TnT measurement during the first 3 days after surgery was significantly associated with 30-day mortality. JAMA. 2012;307(21):2295-2304 www.jama.com

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据